Skip to main content
SpringerLink
Log in
Book cover

Handbuch Psychoaktive Substanzen pp 1–30Cite as

Beruhigungsmittel: Sedativa und Hypnotika

  • Living reference work entry
  • First Online:

  • 861 Accesses

Part of the book series: Springer Reference Psychologie ((SRP))

Zusammenfassung

Beruhigungs- und Schlafmittel finden seit Entwicklung der ersten Substanz 1832 breiten medizinischen Einsatz ebenso wie rekreationale und missbräuchliche Verwendung. Sie zählen zu den am häufigsten verschriebenen Medikamenten. Erlangten viele der älteren Substanzen traurige Berühmtheit durch ihre Verwendung bei Suiziden, so zeichnen sich die neueren Vertreter durch eine hohe therapeutische Breite bei alleiniger Anwendung aus. Das Abhängigkeits- und Suchtpotenzial bleibt jedoch trotz vieler Weiterentwicklungen und Einführung nebenwirkungsärmerer Präparate ein Hauptproblem der Behandlung. Intoxikationen ebenso wie körperliche Entzugssymptome können lebensbedrohliche Ausmaße annehmen und stellen einen häufigen Grund für die Notwendigkeit einer notfallmäßigen stationären Behandlung dar. Entscheidend ist daher die Prävention von Medikamentenabhängigkeit bei Vertretern dieser Substanzklasse.

This is a preview of subscription content, log in via an institution.

Literatur

  • Allonen, H., Ziegler, G., & Klotz, U. (1981). Midazolam kinetics. Clinical Pharmacology and Therapeutics, 30(5), 653–661.

    Article  PubMed  Google Scholar 

  • Amato, L., Minozzi, S., Vecchi, S., & Davoli, M. (2010). Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews, 3, CD005063. doi:10.1002/14651858.CD005063.pub3.

    Google Scholar 

  • Amato, L., Davoli, M., Vecchi, S., Ali, R., Farrell, M., Faggiano, F., … & Chengzheng, Z. (2011). Cochrane systematic reviews in the field of addiction: What’s there and what should be. Drug Alcohol Depend, 113(2–3), 96–103. doi:10.1016/j.drugalcdep.2010.08.003.

    Google Scholar 

  • Andriamampandry, C., Taleb, O., Kemmel, V., Humbert, J. P., Aunis, D., & Maitre, M. (2007). Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB Journal, 21(3), 885–895. doi:10.1096/fj.06-6509com.

    Article  PubMed  Google Scholar 

  • Apothekerverbände, B. f. G. A. B. D. (2013). Sachbericht Modellprojekt Ambulanter Entzug Benzodiazepin-abhängiger Patienten in Zusammenarbeit von Apotheker und Hausarzt. https://www.bundesgesundheitsministerium.de/ministerium/ressortforschung/krankheitsvermeidung-und-bekaempfung/drogen-und-sucht/verbesserung-von-beratung-behandlung-und-therapie/ambulanter-entzug-benzodiazepin-abhaengiger-patient.html.. Zugegriffen am 31.03.2017.

  • AWMF, D., & DG-Sucht. (2015). S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen. http://www.awmf.org/uploads/tx_szleitlinien/076-001l_S3-Leitlinie_Alkohol_2016-02.pdf. Zugegriffen am 31.03.2017.

  • Bachhuber, M. A., Hennessy, S., Cunningham, C. O., & Starrels, J. L. (2016). Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. American Journal of Public Health, 106(4), 686–688. doi:10.2105/AJPH.2016.303061.

    Article  PubMed  PubMed Central  Google Scholar 

  • Backmund, M., Meyer, K., Henkel, C., Soyka, M., Reimer, J., & Schutz, C. G. (2005). Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. Journal of Addictive Diseases, 24(4), 17–29.

    Article  PubMed  Google Scholar 

  • Balter, M. B., Levine, J., & Manheimer, D. I. (1974). Cross-national study of the extent of anti-anxiety-sedative drug use. New England Journal of Medicine, 290(14), 769–774. doi:10.1056/NEJM197404042901404.

    Article  PubMed  Google Scholar 

  • Balter, M. B., Manheimer, D. I., Mellinger, G. D., & Uhlenhuth, E. H. (1984). A cross-national comparison of anti-anxiety/sedative drug use. Current Medical Research and Opinion, 8(Suppl 4), 5–20.

    PubMed  Google Scholar 

  • Bandelow, B., Lichte, T., & Rudolf, S. et al. (2015). Eur Arch Psychiatry Clin Neurosci, 265, 363. doi:10.1007/s00406-014-0563-z.

    Google Scholar 

  • Benedict, S., & Chelouche, T. (2008). Meseritz-Obrawalde: A ‚wild euthanasia‘ hospital of Nazi Germany. History of Psychiatry, 19(73 Pt 1), 68–76.

    Article  PubMed  Google Scholar 

  • Benkert, O., Hippius, H., et al. (2014). Kompendium der Psychiatrischen Pharmakotherapie (10. Aufl.). Berlin: Springer-Verlag.

    Google Scholar 

  • Bennett, W. R., Wilson, L. G., & Roy-Byrne, P. P. (2007). Gamma-hydroxybutyric acid (GHB) withdrawal: A case report. Journal of Psychoactive Drugs, 39(3), 293–296. doi:10.1080/02791072.2007.10400616.

    Article  PubMed  Google Scholar 

  • Bond, A., Seijas, D., Dawling, S., & Lader, M. (1994). Systemic absorption and abuse liability of snorted flunitrazepam. Addiction, 89(7), 821–830.

    Article  PubMed  Google Scholar 

  • Bonkers Institute for Nearly Genuine Research (Producer). (2009, July 22nd, 2016). Truly marvelous mental medicine psychoneuropharmacological women’s issues. http://www.bonkersinstitute.org/medshow/femfree.html. Zugegriffen am 22.07.2016.

  • Bowart, W. (2016). Operation mind control – The PARANOIA edition. Lulu.com. North Carolina: Lulu Press, Inc. Raleigh.

    Google Scholar 

  • Brand, H., Künzel, J., & Braun, B. (2015). SUCHTHILFE IN DEUTSCHLAND 2014 – JAHRESBERICHT DER DEUTSCHEN SUCHTHILFESTATISTIK (DSHS). http://www.suchthilfestatistik.de/fileadmin/user_upload_dshs/Publikationen/Jahresberichte/DSHS_Jahresbericht_2014.pdf. Zugegriffen am 31.03.2017.

  • Brown, R. E. (2007). Alfred McCoy, Hebb, the CIA and torture. Journal of the History of the Behavioral Sciences, 43(2), 205–213. doi:10.1002/jhbs.20225.

    Article  PubMed  Google Scholar 

  • Bumm, R. (1927). Intravenöse Narkosen mit Barbitursäurederivaten. Klinische Wochenschrift, 6, 725–726.

    Article  Google Scholar 

  • Bundesärztekammer. (2007). Hinweise zur Behandlung von Patienten mit schädlichem Medikamentengebrauch oder Medikamentenabhängigkeit. http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/MedikamentenabhaengigkeitMerkblatt.pdf. Zugegriffen am 18.06.2016.

  • Busardo, F. P., & Jones, A. W. (2015). GHB pharmacology and toxicology: Acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Current Neuropharmacology, 13(1), 47–70. doi:10.2174/1570159X13666141210215423.

    Article  PubMed  PubMed Central  Google Scholar 

  • Calhoun, S. R., Wesson, D. R., Galloway, G. P., & Smith, D. E. (1996). Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and south Texas. Journal of Psychoactive Drugs, 28(2), 183–189. doi:10.1080/02791072.1996.10524390.

    Article  PubMed  Google Scholar 

  • Cameron, D. E. (1956). Psychic driving. American Journal of Psychiatry, 112(7), 502–509. doi:10.1176/ajp.112.7.502.

    Article  PubMed  Google Scholar 

  • Carter, L. P., Richards, B. D., Mintzer, M. Z., & Griffiths, R. R. (2006). Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology, 31(11), 2537–2551. doi:10.1038/sj.npp.1301146.

    Article  PubMed  Google Scholar 

  • Chawla, D., & Parmar, V. (2010). Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: A systematic review and meta-analysis. Indian Pediatrics, 47(5), 401–407.

    Article  PubMed  Google Scholar 

  • Cimolai, N. (2007). Zopiclone: Is it a pharmacologic agent for abuse? Canadian Family Physician, 53(12), 2124–2129.

    PubMed  PubMed Central  Google Scholar 

  • Conrad, M., & Guthzeit, M. (1882). Über Barbitursäurederivate. Berichte der Deutschen Chemischen Gesellschaft, 15, 2844–2850.

    Article  Google Scholar 

  • Cousto, H. (2011). Fachinformation: GHB (Gamma-Hydroxybutyrat) – Mischkonsum. http://www.drogenkult.net/index.php/GHB.pdf?file=GHB&view=pdf. Zugegriffen am 18.06.2016.

  • Darker, C. D., Sweeney, B. P., Barry, J. M., Farrell, M. F., & Donnelly-Swift, E. (2015). Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database of Systematic Reviews, 5, CD009652. doi:10.1002/14651858.CD009652.pub2.

    PubMed  Google Scholar 

  • de Jong, C. A., Kamal, R., Dijkstra, B. A., & de Haan, H. A. (2012). Gamma-hydroxybutyrate detoxification by titration and tapering. European Addiction Research, 18(1), 40–45. doi:10.1159/000333022.

    Article  PubMed  Google Scholar 

  • DEA (Producer). (June 18th, 2016). https://www.dea.gov/druginfo/concerns.shtml. Zugegriffen am 18.06.2016.

  • Denis, C., Fatseas, M., Lavie, E., & Auriacombe, M. (2006). Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database of Systematic Reviews, 3, CD005194. doi:10.1002/14651858.CD005194.pub2.

    Google Scholar 

  • DGN. (2012). http://www.awmf.org/uploads/tx_szleitlinien/030-011l_S1_Tremor_2012-verlaengert.pdf. Zugegriffen am 31.03.2017.

  • ElSohly, M. A., & Salamone, S. J. (1999). Prevalence of drugs used in cases of alleged sexual assault. Journal of Analytical Toxicology, 23(3), 141–146.

    Article  PubMed  Google Scholar 

  • Epifanio, G. (1915). L’ipnosi farmacologica prolungata e sua applicazione per la cura di alcune psicopatici. Rivista di Patologia Nervosa e Mentale, 20, 273–308.

    Google Scholar 

  • Erowid (Producer). (2004, June 26th, 2016). Benzodiazepine – Bits & pieces. https://www.erowid.org/pharms/benzodiazepine/benzodiazepine_bits.shtml. Zugegriffen am 26.06.2016.

  • Expert Committee on Drug Dependence, W. (2012). Gamma-hydroxybutyric acid (GHB) – Critical review report, 35th ECDD (2012) Agenda item 4.1. Paper presented at the Expert Committee on Drug Dependence – Thirty-fifth meeting, Hammamet.

    Google Scholar 

  • Farre, M., Teran, M. T., Roset, P. N., Mas, M., Torrens, M., & Cami, J. (1998). Abuse liability of flunitrazepam among methadone-maintained patients. Psychopharmacology, 140(4), 486–495.

    Article  PubMed  Google Scholar 

  • Fischer, A. (2007). Erzwungener Freitod. Spuren und Zeugnisse in den Freitod getriebener Juden der Jahre 1938–1945 in Berlin. Berlin: Textpunkt.

    Google Scholar 

  • Fischer, E., & von Mering, J. (1903). Ueber ein neue Klasse von Schlafmitteln. Therapie der Gegenwart, 44, 97–101.

    Google Scholar 

  • Floyd, J. (1990). The administration of psychotropic drugs to prisoners: State of the law and beyond. California Law Review, 78(5), 1243–1285.

    Article  PubMed  Google Scholar 

  • Friedan, B. (2010). The problem that has no name. The Feminine Mystique 1963. American Journal of Public Health, 100(9), 1582–1584.

    Article  PubMed  Google Scholar 

  • Gastaut, H., Naquet, R., Poire, R., & Tassinari, C. A. (1965). Treatment of status epilepticus with Diazepam (Valium). Epilepsia, 6, 167–182.

    Article  PubMed  Google Scholar 

  • George, C. F. (2001). Pyrazolopyrimidines. Lancet, 358(9293), 1623–1626.

    Article  PubMed  Google Scholar 

  • Gin, T. (2013). Hypnotic and sedative drugs – Anything new on the horizon? Current Opinion in Anaesthesiology, 26(4), 409–413. doi:10.1097/ACO.0b013e328362a7a3.

    PubMed  Google Scholar 

  • Gjerde, H., Nordfjaern, T., Bretteville-Jensen, A. L., Edland-Gryt, M., Furuhaugen, H., Karinen, R., et al. (2015). Comparison of drugs used by nightclub patrons and criminal offenders in Oslo, Norway. Forensic Science International, 265, 1–5. doi:10.1016/j.forsciint.2015.12.029.

    Article  PubMed  Google Scholar 

  • Glaeske, G. (2015). Medikamente 2013 – Psychotrope und andere Arzneimittel mit Missbrauchs- und Abhängigkeitspotenzial. In Deutsche Hauptstelle für Suchtfragen (DHS): Jahrbuch Sucht 2015. Lengerich: Pabst.

    Google Scholar 

  • Gossop, M. (1993). The La Roche affair. In M. Gossop (Hrsg.), Living with drugs (S. 53–55). London: Ashgate.

    Google Scholar 

  • Gray, S. L., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R. A., … & Larson, E. B. (2016). Benzodiazepine use and risk of incident dementia or cognitive decline: Prospective population based study. BMJ, 352, i90. doi:10.1136/bmj.i90.

    Google Scholar 

  • Greenblatt, D. J., & Shader, R. I. (1978). Dependence, tolerance, and addiction to benzodiazepines: Clinical and pharmacokinetic considerations. Drug Metabolism Reviews, 8(1), 13–28. doi:10.3109/03602537808993775.

    Article  PubMed  Google Scholar 

  • Griffith, P. A., & Karp, H. R. (1980). Lorazepam in therapy for status epilepticus. Annals of Neurology, 7(5), 493. doi:10.1002/ana.410070520.

    Article  PubMed  Google Scholar 

  • Gunja, N. (2013). The clinical and forensic toxicology of Z-drugs. Journal of Medical Toxicology, 9(2), 155–162. doi:10.1007/s13181-013-0292-0.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hagenbuch, F. (2011). GBL/GHB – der neue Kick? Das Wichtigste für die Praxis im Überblick. https://www.aerztekammer-bw.de/10aerzte/05kammern/10laekbw/20ehrenamt/30ausschuesse/suchtmedizin/suchtmedizin/gbl-ghb.pdf. Zugegriffen am 11.05.2016.

  • Hauptmann, A. (1912). Luminal bei Epilepsie. Münchener Medizinische Wochenschrift (1950), 59, 1907.

    Google Scholar 

  • Heizmann, P., Eckert, M., & Ziegler, W. H. (1983). Pharmacokinetics and bioavailability of midazolam in man. British Journal of Clinical Pharmacology, 16(Suppl 1), 43S–49S.

    Article  PubMed  PubMed Central  Google Scholar 

  • Herzberg, D. (2009). Happy Pills in America: From Miltown to Prozac. Baltimore: Johns Hopkins University Press.

    Google Scholar 

  • Hoffman, R. S., Wipfler, M. G., Maddaloni, M. A., & Weisman, R. S. (1991). Has the New York State triplicate benzodiazepine prescription regulation influenced sedative-hypnotic overdoses? New York State Journal of Medicine, 91(10), 436–439.

    PubMed  Google Scholar 

  • Hollister, L. E., Motzenbecker, F. P., & Degan, R. O. (1961). Withdrawal reactions from chlordiazepoxide („Librium“). Psychopharmacologia, 2, 63–68.

    Article  PubMed  Google Scholar 

  • Horwitz, A. V. (2009). Happy pills in America: From Miltown to Prozac. The age of anxiety: A history of America’s turbulent affair with tranquilizers before Prozac: The troubled history of mood disorders in psychiatry. New England Journal of Medicine, 360, 841–844.

    Article  Google Scholar 

  • Horwitz, A. V. (2010). How an age of anxiety became an age of depression. Milbank Quarterly, 88(1), 112–138. doi:10.1111/j.1468-0009.2010.00591.x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hosfeld, R. (2012). Tucholsky. Ein deutsches Leben. München: Siedler Verlag.

    Google Scholar 

  • Hunter, A. S., Long, W. J., & Ryrie, C. G. (1971). An evaluation of gamma-hydroxybutyric acid in paediatric practice. British Journal of Anaesthesia, 43(6), 620–628.

    Article  PubMed  Google Scholar 

  • Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 125(1–2), 8–18. doi:10.1016/j.drugalcdep.2012.07.004.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jordan, A. C. (1904). Veronal: A new hypnotic. British Medical Journal, 1(2253), 538–539.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kaiser, T. O. H. (2015). Klaus. Mann. Ein Schriftsteller in den Fluten der Zeit: Bestandsaufnahme und kritische Würdigung von Leben und Werk. BoD-Books on Demand.

    Google Scholar 

  • Kam, P. C., & Yoong, F. F. (1998). Gamma-hydroxybutyric acid: An emerging recreational drug. Anaesthesia, 53(12), 1195–1198.

    Article  PubMed  Google Scholar 

  • Keating, G. M. (2014). Sodium oxybate: A review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clinical Drug Investigation, 34(1), 63–80. doi:10.1007/s40261-013-0158-x.

    Article  PubMed  Google Scholar 

  • Klaesi, J. (1922). Ueber die therapeutische Anwendung der ‚Dauernarkose‘ mittels Somnifen bei Schizophrenen. Z Ges Neurology Psychiatry, 74, 557.

    Article  Google Scholar 

  • Kläsi, J. (1921). Ueber Somnifen, eine medikamentöse Therapie schizophrener Aufregungszustände. Archives of Neurology and Psychiatry, 8, 131.

    Google Scholar 

  • Köhler, T. (2014). Rauschdrogen und andere psychotrope Substanzen. DGVT Deutsche Gesellschaft f. Verhaltenstherapie.

    Google Scholar 

  • Kriegbaum, M., Hendriksen, C., Vass, M., Mortensen, E. L., & Osler, M. (2015). Hypnotics and mortality – Partial confounding by disease, substance abuse and socioeconomic factors? Pharmacoepidemiology and Drug Safety, 24(7), 779–783. doi:10.1002/pds.3745.

    Article  PubMed  Google Scholar 

  • Laborit, H. (1964). Sodium 4-Hydroxybutyrate. International Journal of Neuropharmacology, 3, 433–451.

    Article  PubMed  Google Scholar 

  • Lader, M. (1978). Benzodiazepines – The opium of the masses? Neuroscience, 3(2), 159–165.

    Article  PubMed  Google Scholar 

  • Lader, M. (2011). Benzodiazepines revisited – Will we ever learn? Addiction, 106(12), 2086–2109. doi:10.1111/j.1360-0443.2011.03563.x.

    Article  PubMed  Google Scholar 

  • Lohse, M. J., & Bruno, M.-O. (2014). Hypnotika und Sedativa Arzneiverordnungsreport.

    Google Scholar 

  • Lopez-Munoz, F., Ucha-Udabe, R., & Alamo, C. (2005). The history of barbiturates a century after their clinical introduction. Neuropsychiatric Disease and Treatment, 1(4), 329–343.

    PubMed  PubMed Central  Google Scholar 

  • Lopez-Munoz, F., Alamo, C., & Garcia-Garcia, P. (2011). The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs. Journal of Anxiety Disorders, 25(4), 554–562. doi:10.1016/j.janxdis.2011.01.002.

    Article  PubMed  Google Scholar 

  • Madea, B. E. (2014). Handbook of forensic medicine. Hoboken, New Jersey: Wiley-Blackwell.

    Google Scholar 

  • Mancuso, C. E., Tanzi, M. G., & Gabay, M. (2004). Paradoxical reactions to benzodiazepines: Literature review and treatment options. Pharmacotherapy, 24(9), 1177–1185.

    Article  PubMed  Google Scholar 

  • Manfredi, R. L., & Kales, A. (1987). Clinical neuropharmacology of sleep disorders. Seminars in Neurology, 7(3), 286–295. doi:10.1055/s-2008-1041429.

    Article  PubMed  Google Scholar 

  • Marshall, L. F., Smith, R. W., & Shapiro, H. M. (1979). The outcome with aggressive treatment in severe head injuries. Part II: Acute and chronic barbiturate administration in the management of head injury. Journal of Neurosurgery, 50(1), 26–30. doi:10.3171/jns.1979.50.1.0026.

    Article  PubMed  Google Scholar 

  • Matos, E. G. d., Atzendorf, J., Kraus, L., & Piontek, D. (2016). Substanzkonsum in der Allgemeinbevölkerung in Deutschland: Ergebnisse des Epidemiologischen Suchtsurveys 2015. SUCHT, 62(5), 271–281.

    Google Scholar 

  • Mayo-Smith, M. F. (1997). Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA, 278(2), 144–151.

    Article  PubMed  Google Scholar 

  • Medizinprodukte, B. B. f. A. u. (2013). http://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/Gremien/RoutinesitzungPar63AMG/72Sitzung/pkt-3-2.pdf?__blob=publicationFile&v=2. Zugegriffen am 31.03.2017.

  • Mintzer, M. Z., & Griffiths, R. R. (1998). Flunitrazepam and triazolam: A comparison of behavioral effects and abuse liability. Drug and Alcohol Dependence, 53(1), 49–66.

    Article  PubMed  Google Scholar 

  • Monnier, M. (1936). Die Dauerschlafbehandlung der Schizophrenien mit Narkosenmischung von Cloetta an der Psychiatrischen Klinik Burghölzli – Zürich. Nervenarzt, 9, 14–29.

    Google Scholar 

  • Morin, C. M., & Benca, R. (2012). Chronic insomnia. Lancet, 379(9821), 1129–1141. doi:10.1016/S0140-6736(11)60750-2.

    Article  PubMed  Google Scholar 

  • Müller, H. (1925). Die Dauernarkose mit Somnifen in der Psychiatrie. Ein Überblick. Zeitschrift für die Gesamte Neurologie und Psychiatrie, 96, 653–682.

    Article  Google Scholar 

  • n.s. (1998). Chloral hydrate: A risky old psychotropic drug. Prescrire Int, 7(35), 88–89.

    Google Scholar 

  • n.s. (2002). A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep, 25(1), 42–49.

    Google Scholar 

  • NICE. (2011). National Institute for Health and Clinical Excellence: Guidance Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence (CG115). Leicester (UK).

    Google Scholar 

  • Nimmerrichter, A. A., Walter, H., Gutierrez-Lobos, K. E., & Lesch, O. M. (2002). Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol and Alcoholism, 37(1), 67–73.

    Article  PubMed  Google Scholar 

  • Nissen, C., Frase, L., Hajak, G., & Wetter, T. C. (2014). Hypnotics – State of the science. Nervenarzt, 85(1), 67–76. doi:10.1007/s00115-013-3893-6.

    Article  PubMed  Google Scholar 

  • Ntais, C., Pakos, E., Kyzas, P., & Ioannidis, J. P. (2005). Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews, 3, CD005063. doi:10.1002/14651858.CD005063.pub2.

    Google Scholar 

  • Nutt, D. (2006). GABAA receptors: Subtypes, regional distribution, and function. Journal of Clinical Sleep Medicine, 2(2), 7–11.

    Google Scholar 

  • Nutt, D. J., & Feetam, C. L. (2010). What one hand giveth the other taketh away: Some unpredicted effects of enantiomers in psychopharmacology. Journal of Psychopharmacology, 24(8), 1137–1141. doi:10.1177/0269881110374782.

    Article  PubMed  Google Scholar 

  • Nutt, D. J., & Stahl, S. M. (2010). Searching for perfect sleep: The continuing evolution of GABAA receptor modulators as hypnotics. Journal of Psychopharmacology, 24(11), 1601–1612. doi:10.1177/0269881109106927.

    Article  PubMed  Google Scholar 

  • Ohayon, M. M. (2002). Epidemiology of insomnia: What we know and what we still need to learn. Sleep Medicine Reviews, 6(2), 97–111.

    Article  PubMed  Google Scholar 

  • Ohnhäuser, T. (2013). Suizid im Nationalsozialismus. Deutsches Arzteblatt International, 110(7), 266–8.

    Google Scholar 

  • Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72(2), 136–142. doi:10.1001/jamapsychiatry.2014.1763.

    Article  PubMed  Google Scholar 

  • Olkkola, K. T., & Ahonen, J. (2008). Midazolam and other benzodiazepines. Handbook of Experimental Pharmacology, 182, 335–360. doi:10.1007/978-3-540-74806-9_16.

    Article  Google Scholar 

  • Otto, C., Crackau, B., Lohrmann, I., Zahradnik, A., Bischof, G., John, U., et al. (2009). Brief intervention in general hospital for problematic prescription drug use: 12-month outcome. Drug and Alcohol Dependence, 105(3), 221–226. doi:10.1016/j.drugalcdep.2009.07.010.

    Article  PubMed  Google Scholar 

  • Pariente, A., de Gage, S. B., Moore, N., & Begaud, B. (2016). The benzodiazepine-dementia disorders link: Current state of knowledge. CNS Drugs, 30(1), 1–7. doi:10.1007/s40263-015-0305-4.

    Article  PubMed  Google Scholar 

  • Parr, J. M., Kavanagh, D. J., Cahill, L., Mitchell, G., & Mc, D. Y. R. (2009). Effectiveness of current treatment approaches for benzodiazepine discontinuation: A meta-analysis. Addiction, 104(1), 13–24. doi:10.1111/j.1360-0443.2008.02364.x.

    Article  PubMed  Google Scholar 

  • Pathy, M. S. (1974). A double-blind comparison of chlormethiazole and dichloralphenazone: A sedative/hypnotic in geriatric medicine. Current Medical Research and Opinion, 2(10), 648–656.

    Article  PubMed  Google Scholar 

  • Pershad, J., Palmisano, P., & Nichols, M. (1999). Chloral hydrate: The good and the bad. Pediatric Emergency Care, 15(6), 432–435.

    Article  PubMed  Google Scholar 

  • Petitjean, S., Ladewig, D., Meier, C. R., Amrein, R., & Wiesbeck, G. A. (2007). Benzodiazepine prescribing to the Swiss adult population: Results from a national survey of community pharmacies. International Clinical Psychopharmacology, 22(5), 292–298. doi:10.1097/YIC.0b013e328105e0f2.

    Article  PubMed  Google Scholar 

  • Poser, W., Böning, J., Holzbach, R., & Schmidt, L. G. (2006). Medikamentenabhängigkeit (Sedativa, Hypnotika, Analgetika, Psychostimulantien). In L. G. Schmidt, P. Falkai & W. Gaebel (Hrsg.), Evidenzbasierte Suchtmedizin (S. 271–307). Köln: Deutscher Ärzteverlag.

    Google Scholar 

  • Potokar, J., Coupland, N., Wilson, S., Rich, A., & Nutt, D. (1999). Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology, 146(2), 180–184.

    Article  PubMed  Google Scholar 

  • Redlich, F. C., Ravitz, L. J., Jr., & Dession, G. H. (1951). Narcoanalysis and truth. American Journal of Psychiatry, 107(8), 586–593. doi:10.1176/ajp.107.8.586.

    Article  PubMed  Google Scholar 

  • Reilly, T. M. (1976). Physiological dependence on, and symptoms of withdrawal from, chlormethiazole. British Journal of Psychiatry, 128, 375–378.

    Article  PubMed  Google Scholar 

  • Reves, J. G., Fragen, R. J., Vinik, H. R., & Greenblatt, D. J. (1985). Midazolam: Pharmacology and uses. Anesthesiology, 62(3), 310–324.

    Article  PubMed  Google Scholar 

  • Rickels, K. (1978). Use of antianxiety agents in anxious outpatients. Psychopharmacology, 58(1), 1–17.

    Article  PubMed  Google Scholar 

  • Robinson, D. M., & Keating, G. M. (2007). Sodium oxybate: A review of its use in the management of narcolepsy. CNS Drugs, 21(4), 337–354.

    Article  PubMed  Google Scholar 

  • RollingStones. (1966). Mother’s little helpers. On aftermath. London: Decca.

    Google Scholar 

  • Roth, R. H., & Giarman, N. J. (1965). Preliminary report on the metabolism of gamma-butyrolactone and gamma-hydroxybutyric acid. Biochemical Pharmacology, 14, 177–178.

    Article  PubMed  Google Scholar 

  • Roth, R. H., & Giarman, N. J. (1968). Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate. Biochemical Pharmacology, 17(5), 735–739.

    Article  PubMed  Google Scholar 

  • Rutsch, H.-D. (2014). Das preußische Arkadien: Schlesien und die Deutschen. Berlin: Rowohlt Verlag GmbH.

    Google Scholar 

  • Sacks, O. (2012). „Altered states“. The New Yorker. http://www.newyorker.com/magazine/2012/08/27/altered-states-3. Zugegriffen am 31.03.2017.

  • San, L., Tato, J., Torrens, M., Castillo, C., Farre, M., & Cami, J. (1993a). Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification. Drug and Alcohol Dependence, 32(3), 281–286.

    Article  PubMed  Google Scholar 

  • San, L., Torrens, M., Castillo, C., Porta, M., & de la Torre, R. (1993b). Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: Results from cross-sectional studies in 1988 and 1990. Addiction, 88(10), 1341–1349.

    Article  PubMed  Google Scholar 

  • Sateia, M. J., & Nowell, P. D. (2004). Insomnia. Lancet, 364(9449), 1959–1973. doi:10.1016/S0140-6736(04)17480-1.

    Article  PubMed  Google Scholar 

  • Schlafmedizin, D. D. G. f. S. u. (2009). S3-Leitlinie „Nicht erholsamer Schlaf/Schlafstörungen“. Somnologie, 13, 4–160.

    Google Scholar 

  • Schwartz, R. H., & Weaver, A. B. (1998). Rohypnol, the date rape drug. Clinical Pediatrics, 37(5), 321.

    Article  PubMed  Google Scholar 

  • Seksik, L. (2011). Vorgefühl der nahen Nacht (trans: Laak, A. d. F. v. H. v.). München: Karl Blessing Verlag.

    Google Scholar 

  • Shader, R. I., Greenblatt, D. J., & Balter, M. B. (1991). Appropriate use and regulatory control of benzodiazepines. Journal of Clinical Pharmacology, 31(9), 781–784.

    Article  PubMed  Google Scholar 

  • Shapiro, S., & Baron, S. H. (1961). Prescriptions for psychotropic drugs in a noninstitutional population. Public Health Reports, 76(6), 481–488.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shorvon, S. (2000). Handbook of epilepsy treatment. Oxford: Blackwell Science.

    Google Scholar 

  • Snead, O. C., 3rd. (2000). Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. Journal of Neurochemistry, 75(5), 1986–1996.

    Article  PubMed  Google Scholar 

  • Snead, O. C., 3rd, & Gibson, K. M. (2005). Gamma-hydroxybutyric acid. New England Journal of Medicine, 352(26), 2721–2732. doi:10.1056/NEJMra044047.

    Article  PubMed  Google Scholar 

  • Soyka, M. (2016). Medikamentenabhängigkeit. Entstehungsbedingungen – Klinik – Therapie. Stuttgart: Schattauer.

    Google Scholar 

  • Soyka, M. (im Druck). Treatment of benzodiazepine dependence: An overview. New England Journal Of Medicine.

    Google Scholar 

  • Stahl, S. M. (2013). Stahl’s essential psychopharmacology (4., überarb. Aufl.). Cambridge, UK: Cambridge University Press.

    Google Scholar 

  • Substance Abuse and Mental Health Services Administration. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194). Rockville, MD.

    Google Scholar 

  • Sullivan, G., McBride, A. J., & Clee, W. B. (1995). Zopiclone abuse in South Wales: Three case reports. Human Psychopharmacology, 10, 351–352.

    Article  Google Scholar 

  • Sumnall, H. R., Woolfall, K., Edwards, S., Cole, J. C., & Beynon, C. M. (2008). Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug and Alcohol Dependence, 92(1–3), 286–290. doi:10.1016/j.drugalcdep.2007.07.009.

    Article  PubMed  Google Scholar 

  • Taipale, H., Koponen, M., Tanskanen, A., Tolppanen, A. M., Tiihonen, J., & Hartikainen, S. (2015). Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer’s disease. International Clinical Psychopharmacology, 30(4), 202–208. doi:10.1097/YIC.0000000000000080.

    Article  PubMed  Google Scholar 

  • Takahara, J., Yunoki, S., Yakushiji, W., Yamauchi, J., & Yamane, Y. (1977). Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. Journal of Clinical Endocrinology and Metabolism, 44(5), 1014–1017. doi:10.1210/jcem-44-5-1014.

    Article  PubMed  Google Scholar 

  • Tan, K. R., Brown, M., Labouebe, G., Yvon, C., Creton, C., Fritschy, J. M., … & Luscher, C. (2010). Neural bases for addictive properties of benzodiazepines. Nature, 463(7282), 769–774. doi:10.1038/nature08758.

    Google Scholar 

  • Teter, C. J., & Guthrie, S. K. (2001). A comprehensive review of MDMA and GHB: Two common club drugs. Pharmacotherapy, 21(12), 1486–1513.

    Article  PubMed  Google Scholar 

  • Thai, D., Dyer, J. E., Jacob, P., & Haller, C. A. (2007). Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Clinical Pharmacology and Therapeutics, 81(2), 178–184. doi:10.1038/sj.clpt.6100037.

    Article  PubMed  Google Scholar 

  • TIME. (1952). Misanthrope from Japon. Time Magazine.

    Google Scholar 

  • Tone, A. (2009). The age of anxiety: A history of America’s turbulent affair with tranquilizers. New York: Basic Books.

    Google Scholar 

  • Tyrer, P. (1974). The benzodiazepine bonanza. Lancet, 2(7882), 709–710.

    Article  PubMed  Google Scholar 

  • U. S. Xyrem Multicenter Study Group. (2004). Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Medicine, 5(2), 119–123. doi:10.1016/j.sleep.2003.11.002.

    Article  Google Scholar 

  • Usher, S. (2015). More letters of note: Correspondence deserving of a wider audience. Canongate Unbound. Scotland: Edinburgh.

    Google Scholar 

  • Vagts, D. A. (2007). Suchtmittel in der AINS. Berlin: Springer-Verlag.

    Book  Google Scholar 

  • Van Cauter, E., Plat, L., Scharf, M. B., Leproult, R., Cespedes, S., L’Hermite-Baleriaux, M., et al. (1997). Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. Journal of Clinical Investigation, 100(3), 745–753. doi:10.1172/JCI119587.

    Article  PubMed  PubMed Central  Google Scholar 

  • van Noorden, M. S., van Dongen, L. C., Zitman, F. G., & Vergouwen, T. A. (2009). Gamma-hydroxybutyrate withdrawal syndrome: Dangerous but not well-known. General Hospital Psychiatry, 31(4), 394–396. doi:10.1016/j.genhosppsych.2008.11.001.

    Article  PubMed  Google Scholar 

  • Victorri-Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007). Evidence of zolpidem abuse and dependence: Results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. British Journal of Clinical Pharmacology, 64(2), 198–209. doi:10.1111/j.1365-2125.2007.02861.x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Victorri-Vigneau, C., Gerardin, M., Rousselet, M., Guerlais, M., Grall-Bronnec, M., & Jolliet, P. (2014). An update on zolpidem abuse and dependence. Journal of Addictive Diseases, 33(1), 15–23. doi:10.1080/10550887.2014.882725.

    Article  PubMed  Google Scholar 

  • Von Baeyer, A. (1864). Untersuchungen über die Harnsauregruppe. Annalen, 130, 129.

    Article  Google Scholar 

  • Vozeh, S. (1981). Pharmacokinetic of benzodiazepines in old age. Schweizerische Medizinische Wochenschrift, 111(47), 1789–1793.

    PubMed  Google Scholar 

  • Weber, M. M. (1999). Die Entwicklung der Psychopharmakologie im Zeitalter der naturwissenschaftlichen Medizin: Ideengeschichte eines psychiatrischen Therapiesystems. Berlin: Urban und Vogel Verlag.

    Google Scholar 

  • Whiting, P. J. (2003). The GABAA receptor gene family: New opportunities for drug development. Current Opinion in Drug Discovery & Development, 6(5), 648–657.

    Google Scholar 

  • Wilby, M. J., & Hutchinson, P. J. (2004). The pharmacology of chlormethiazole: A potential neuroprotective agent? CNS Drug Reviews, 10(4), 281–294.

    Article  PubMed  Google Scholar 

  • Wood, D. M., Warren-Gash, C., Ashraf, T., Greene, S. L., Shather, Z., Trivedy, C., … & Dargan, P. I. (2008). Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM, 101(1), 23–29. doi:10.1093/qjmed/hcm117.

    Google Scholar 

  • Zvosec, D. L., & Smith, S. W. (2003). Unsupported „Efficacy“ claims of gamma hydroxybutyrate (GHB). Academic Emergency Medicine, 10(1), 95–96; author reply 96.

    Article  PubMed  Google Scholar 

  • Zvosec, D. L., Smith, S. W., Porrata, T., Strobl, A. Q., & Dyer, J. E. (2011). Case series of 226 gamma-hydroxybutyrate-associated deaths: Lethal toxicity and trauma. American Journal of Emergency Medicine, 29(3), 319–332. doi:10.1016/j.ajem.2009.11.008.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Berlin, Deutschland

    Jonathan Henssler

  2. Campus Virchow-Klinikum, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Theresa Schubert

  3. Klinik für Psychiatrie und Psychotherapie, Ludwig-Maximilians-Universität, Nußbaumstr. 7, 80336, München, Deutschland

    Michael Soyka

Authors
  1. Jonathan Henssler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theresa Schubert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Soyka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Henssler .

Editor information

Editors and Affiliations

  1. FINDER academy and research , Berlin, Germany

    Maximilian von Heyden

  2. FINDER academy and research , Berlin, Germany

    Henrik Jungaberle

  3. St. Hedwig Krankenhaus, Charité Universitätsmedizin Berlin St. Hedwig Krankenhaus, Berlin, Berlin, Germany

    Tomislav Majić

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag GmbH Deutschland

About this entry

Cite this entry

Henssler, J., Schubert, T., Soyka, M. (2016). Beruhigungsmittel: Sedativa und Hypnotika. In: von Heyden, M., Jungaberle, H., Majić, T. (eds) Handbuch Psychoaktive Substanzen. Springer Reference Psychologie . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55214-4_30-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55214-4_30-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-55214-4

  • Online ISBN: 978-3-642-55214-4

  • eBook Packages: Springer Referenz Psychologie

Publish with us

Policies and ethics

Search

Navigation